Report copyright - ERCC ERCC-1 and response to chemotherapy · Platin-based chemotherapy is the mainstay 3 of first-line treatment for NSCLC 1.0 0.8 0.6 0.4 0.2 0 0 5 10 15 20 25 30 Months Cisplatin/paclitaxel
Please pass captcha verification before submit form